David U’Prichard

President at Druid Consulting LLC

David U’Prichard

David U’Prichard

President at Druid Consulting LLC

Overview
Career Highlights

Druid Consulting LLC
Smithkline Beecham Pharmaceuticals (India) Ltd.
3-Dimensional Pharmaceuticals, Inc.

RelSci Relationships

1392

Number of Boards

40

Birthday

1949

Age

71

Contact Data
Trying to get in touch with David U’Prichard? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals David U’Prichard likely has professional access to. A relationship does not necessarily indicate a personal connection.

Manager & Chairman at Allinaire Therapeutics LLC

Relationship likelihood: Strong

Chairman at iCeutica Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Iroko Pharmaceuticals LLC

Relationship likelihood: Strong

Manager at Dual Therapeutics LLC

Relationship likelihood: Strong

Chairman at BioMotiv LLC

Relationship likelihood: Strong

President & Chief Executive Officer at iCeutica Pharmaceuticals, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Cyclacel Pharmaceuticals Inc.

Relationship likelihood: Strong

Former Senior Executive Vice President & Chief Administrative Officer at Rite Aid Corp.

Relationship likelihood: Strong

Former Director General at Confederation of British Industry

Relationship likelihood: Strong

Venture Partner at SV Health Investors LLP

Relationship likelihood: Strong

Paths to David U’Prichard
Potential Connections via
Relationship Science
You
David U’Prichard
President at Druid Consulting LLC
Education
B.S. in Pharmacology with First-Class Honors

Founded in 1451, Glasgow is the fourth-oldest university in the English-speaking world. Over the last five centuries and more, we’ve constantly worked to push the boundaries of what’s possible. We’ve fostered the talents of seven Nobel laureates, one Prime Minister and Scotland’s inaugural First Minister. We’ve welcomed Albert Einstein to give a lecture on the origins of the general theory of relativity. Scotland’s first female medical graduates completed their degrees here in 1894 and the world’s first ultrasound images of a foetus were published by Glasgow Professor Ian Donald in 1958. In 1840 we became the first university in the UK to appoint a Professor of Engineering, and in 1957, the first in Scotland to have an electronic computer. All of this means that if you choose to work or study here, you’ll be walking in the footsteps of some of the world’s most renowned innovators, from scientist Lord Kelvin and economist Adam Smith, to the pioneer of television John Logie Baird.

Ph.D. in Pharmacology

The University of Kansas (KU) is a public research university and the largest university in the State of Kansas. KU campuses are located in Lawrence, Wichita, Overland Park, Salina, and Kansas City, Kansas, with the main campus located in Lawrence on Mount Oread, the highest location in Lawrence. The University was opened in 1866, under a charter granted by the Kansas Legislature in 1864.

Career History
Chairman, Research & Development
Tenure Unconfirmed
General Manager, Research Department
1986 - 1997

ICI Pharmaceuticals is a Health Care company.

Scientific Director & Senior Vice President
1983 - Prior
Boards & Committees
Chairman, Board of Directors
2004 - Current

Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company builds a biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.

Chairman of the Board
Current

Orca Pharmaceuticals Ltd. operates as a biotechnology company that develops oral drugs for the treatment of chronic inflammatory diseases. It also develops oral drug for the treatment a spectrum of autoimmune diseases that includes psoriasis, ankylosing spondylitis and inflammatory bowel disease. The company was founded by Michael Hunter, Roy Pettipher, Dan Littman, and Jun R. Huh in 2012 and is headquartered in Abingdon, the United Kingdom.

Director
Current

Dual Therapeutics LLC develops novel therapeutics for prostate cancer, lung cancer, and acute lymphoblastic leukemia. The company was founded in 2013 and is headquartered in Cleveland, OH.

Member, Board of Trustees
Current

TO MAINTAIN A DIVERSE AND WELCOMING COMMUNITY FOR SCHOLARS FROM AROUND THE WORLD, WHILE INTRODUCING THEM TO THE AMERICAN EXPERIENCE; SOURCE OF DISTINCTIVE PROGRAMMING.

Director
Prior - 2020

BioMotiv LLC operates as a research institution in the field of therapeutics. It focuses in disease areas and classes of therapeutics such as small molecules, antibodies, proteins, and nucleotides. The company was founded on September 10, 2012 and is headquartered in Cleveland, OH.

Chairman, Board of Directors
2004 - 2005

ENSURE PENNSYLVANIA IS THE UNITED STATES HUB FOR THE LIFE SCIENCES BY CREATING A BUSINESS AND PUBLIC POLICY ENVIRONMENT WHICH FOSTERS LIFE SCIENCES GROWTH AND SUCCESS.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$1,001 - $5,000
2012

William J. Clinton Foundation works to alleviate poverty, improve global health, strengthen economies, and protects the environment, by fostering partnerships among governments, businesses, nongovernmental organizations (NGOs) and private citizens. The foundation focuses on worldwide issues that demand urgent action, solutions, and measurable results - global climate change, HIV/AIDS in the developing world, childhood obesity & economic opportunity in the United States, and economic development in Africa and Latin America.

$1,000 - $4,999
2004

TO MAINTAIN A DIVERSE AND WELCOMING COMMUNITY FOR SCHOLARS FROM AROUND THE WORLD, WHILE INTRODUCING THEM TO THE AMERICAN EXPERIENCE; SOURCE OF DISTINCTIVE PROGRAMMING.

Political Donations
Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations

David U’Prichard is affiliated with Smithkline Beecham Pharmaceuticals (India) Ltd., ICI Pharmaceuticals, Nova Pharmaceutical Corp., Care Capital LLC, Red Abbey Venture Partners LLC, Apax Partners Ltd., Druid Consulting LLC, Druid BioVentures LLC, Johns Hopkins University, 3-Dimensional Pharmaceuticals, Inc., University of Pennsylvania, BioMotiv LLC, Northwestern University - Feinberg School of Medicine, Red Abbey LLC, Dual Therapeutics LLC, Orca Pharmaceuticals Ltd., University of Glasgow, Zeneca Pharmaceuticals, Cyclacel Pharmaceuticals Inc., Orca Pharmaceuticals Ltd., Dual Therapeutics LLC, CoGenesys, Inc., Riverside Partners LLC, British Expats in Life Sciences, Vala Sciences, Inc., Arix Bioscience Plc, Stratified Medicine Scotland, Audeo Oncology, Inc., SMART Biosciences, Inc., Silence Therapeutics PLC, Anesiva, Inc., Zoetis Products LLC, Guilford Pharmaceuticals, Inc., Lynx Therapeutics, Inc., Cyclacel Group Plc, Oxagen Ltd., Invitrogen Corp., Life Technologies Corp., 3-Dimensional Pharmaceuticals, Inc., Ocimum Bio Solutions (India) Ltd., Naurex, Inc., Life Sciences Research, Inc., Atugen AG, Ocimum Biosolutions, Inc., Alpharma, Inc. /Animal Health Division, Predict, Inc., iCeutica Pharmaceuticals, Inc., Corridor Pharmaceuticals, Inc., Iroko Pharmaceuticals LLC, Splash Pharmaceuticals, Inc., Iroko Pharmaceuticals, Inc., International House of Philadelphia, BioMotiv LLC, Life Sciences Pennsylvania, Biotechnology Innovation Organization, Ben Franklin Technology Partners of Southeastern Pennsylvania, The Biotechnology Greenhouse Corp. of Southeastern PA, University of Pennsylvania - Perelman School of Medicine, The Wilma Theater, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by David U’Prichard. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of David U’Prichard's profile does not indicate a business or promotional relationship of any kind between RelSci and David U’Prichard.